Free Trial

Conduit Pharmaceuticals (CDT) News Today

Conduit Pharmaceuticals logo
$0.09 0.00 (0.00%)
(As of 11/20/2024 ET)
Conduit Pharmaceuticals Announces Leadership Changes and Bylaws Update
Conduit Pharmaceuticals announces new addition to autoimmune pipeline
Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements
Conduit Pharmaceuticals Shares Soar In Pre-market, Why?
4 Stocks Moving Sharply Before the Market Opens
Conduit Pharmaceuticals Inc. stock logo
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Sees Large Increase in Short Interest
Conduit Pharmaceuticals Inc. (NASDAQ:CDT - Get Free Report) saw a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 56,800 shares, an increase of 72.6% from the May 31st total of 32,900 shares. Approximately 0.6% of the shares of the company are short sold. Based on an average daily trading volume, of 44,100 shares, the short-interest ratio is currently 1.3 days.
Conduit Pharmaceuticals Inc. stock logo
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Sees Significant Decrease in Short Interest
Conduit Pharmaceuticals Inc. (NASDAQ:CDT - Get Free Report) was the recipient of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 55,100 shares, a decrease of 29.2% from the March 15th total of 77,800 shares. Currently, 0.5% of the shares of the company are short sold. Based on an average daily volume of 39,800 shares, the days-to-cover ratio is currently 1.4 days.
Conduit Pharmaceuticals Inc. stock logo
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Short Interest Up 12.8% in March
Conduit Pharmaceuticals Inc. (NASDAQ:CDT - Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 77,800 shares, a growth of 12.8% from the February 29th total of 69,000 shares. Currently, 0.8% of the shares of the company are sold short. Based on an average daily volume of 43,400 shares, the days-to-cover ratio is currently 1.8 days.
Conduit Pharmaceuticals Adds Key Leadership Positions
Conduit Pharmaceuticals Inc. stock logo
Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Decreases By 39.1%
Conduit Pharmaceuticals Inc. (NASDAQ:CDT - Get Free Report) saw a large drop in short interest during the month of February. As of February 29th, there was short interest totalling 69,000 shares, a drop of 39.1% from the February 14th total of 113,300 shares. Based on an average daily trading volume, of 98,800 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.7% of the shares of the company are sold short.
Conduit Pharmaceuticals Opens New Laboratory in UK
Conduit Pharmaceuticals Inc. stock logo
Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Declines By 13.2%
Conduit Pharmaceuticals Inc. (NASDAQ:CDT - Get Free Report) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 113,300 shares, a decrease of 13.2% from the January 31st total of 130,500 shares. Approximately 1.1% of the company's shares are short sold. Based on an average trading volume of 148,400 shares, the days-to-cover ratio is presently 0.8 days.
Conduit Pharmaceuticals Inc. stock logo
Conduit Pharmaceuticals (NASDAQ:CDT) Trading 6.8% Higher
Conduit Pharmaceuticals (NASDAQ:CDT) Trading Up 6.8%
Conduit Pharmaceuticals Inc. (CDT)
Conduit Pharmaceuticals Inc. (CDTTW)
Conduit Pharmaceuticals Inc.
KXIN and ICU among pre-market losers
CDT Conduit Pharmaceuticals Inc.
Get Conduit Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDT and its competitors with MarketBeat's FREE daily newsletter.

Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

CDT Media Mentions By Week

CDT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CDT
News Sentiment

0.24

0.45

Average
Medical
News Sentiment

CDT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CDT Articles
This Week

2

0

CDT Articles
Average Week

Get Conduit Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CDT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners